$32of $10,000
Neurodevelopmental and neuropsychiatric conditionsResearchHub FoundationMulticenter observational study proposing a 5-epitope plasma phospho-tau Simoa panel plus NfL/GFAP to distinguish PSP, CBD/CBS, AD, and controls (n=480) over 36 months, with pre-registered analyses and open data. Rigorous design and QC scaffolding are strengths, but the $10,000 single-site pilot budget cannot fund the described multicenter study, and the topic does not fit the RFP's neurodevelopmental/neuropsychiatric scope.